IICT sings MoU with US based NDT for developing side effect free cancer drug in 5 years

05:50 EDT 15 Oct 2018 | PharmaBiz

Hyderabad based Indian Institute of Chemical Technology (IICT) has recently signed a Memorandum of Understanding (MoU) with US based Nano Dev Therapeutics (NDT) to conduct clinical trials for developing a

More From BioPortfolio on "IICT sings MoU with US based NDT for developing side effect free cancer drug in 5 years"